Sit Investment Associates »

Silverback Therapeutics shares owned by Sit Investment Associates

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Sit Investment Associates from 13F filings

Historical chart of Sit Investment Associates investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Sit Investment Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Sit Investment Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $749k 75k 10.05
2025-06-30 $704k 40k 17.45

More positions owned by Sit Investment Associates

Nvidia Corp Common (NVDA)
Broadcom Common (AVGO)
Microsoft Corp Common (MSFT)
Angel Oak Financial Strat Common (FINS)
Apple Common (AAPL)
Blackrock Core Bond Trust Bhk Common (BHK)
Blackrock Taxable Muni Bond Tr Common (BBN)
Putnam Premier Income Trust Pp Common (PPT)
Cornerstone Total Return Fd Cr Common (CRF)
Dws Municipal Income Trust Ktf Common (KTF)
Putnam Master Intermediate Common (PIM)
Mfs Intermediate Income Trust Common (MIN)
Alphabet Inc - Cl A Common (GOOGL)
Blackrock Multi Sector Inc Tr Common (BIT)
Blackrock Credit Allocation In Common (BTZ)

View all positions for Sit Investment Associates

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Deerfield Management Company
BlackRock
Rubric Capital Management
Sr One Capital Management
Vanguard Group
Standard Life Aberdeen
State Street Corporation
Alliancebernstein
Franklin Resources
Citadel Advisors
Casdin Capital
Geode Capital Management
Southpoint Capital Advisors

View all funds holding Silverback Therapeutics